Cat. No. Name Size Price Add Cart
KI0139KU-559335 mg$112
KU-5593310 mg$210
KU-5593350 mg$650

Chemical Characteristic

Product NameKU-55933
CAS No.587871-26-9
Molecular Weight 395.49
FormulaC21H17NO3S2
Chemical Name2-morpholino-6-(thianthren-1-yl)-4H-pyran-4-one
Smilesc1(cc(=O)cc(o1)c1cccc2Sc3ccccc3Sc12)N1CCOCC1
Chemical Structure

Biological activities

KU-55933 is a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase (ATM). The IC50 of KU-55933 is 12.9 nM for ATM while the Ki of KU-55933 binding to ATM is 2.2 nM. KU-55933 shows specificity with respect to inhibition of other phosphatidylinositol 3??kinase-like kinases. KU-55933 inhibits DNA-PK and PI3K and mTOR with IC50 of 2.5, 16.6 and 9.3 µM, respectively. Exposure of cells to KU-55933 results in a significant sensitization to the cytotoxic effects of ionizing radiation and to the DNA double-strand break-inducing chemotherapeutic agents, etoposide, doxorubicin, and camptothecin. Inhibition of ATM by KU-55933 also causes a loss of ionizing radiation-induced cell cycle arrest.[1] In parental U251 and U87 glioma lines, the addition of KU-55933 to TMZ significantly increases cell killing compared to TMZ alone. In parental U251 and U87 glioma lines, the addition of KU-55933 to TMZ significantly increases cell killing compared to TMZ alone. [2] KU-55933 blocks the phosphorylation of Akt induced by insulin and insulin-like growth factor I in cancer cells that exhibit abnormal Akt activity. KU-55933 inhibits cancer cell proliferation by inducing G1 cell cycle arrest. KU-55933 treatment during serum starvation triggers apoptosis.[3] KU-55933 not only suppresses p53 and nuclear factor-κB (NF-κB) activation but also notably increases radiation-induced DR5 surface expression. Moreover, KU-55933 down-regulates cFLIP (caspase-8 inhibitor) levels, and substantially enhances exogenous TRAIL-induced apoptosis.[4]

References

[1] Hickson I, et al. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res. 2004, 64(24): 9152-9159.
[2] Nadkarni A, et al. ATM inhibitor KU-55933 increases the TMZ responsiveness of only inherently TMZ sensitive GBM cells. J Neurooncol. 2012.
[3] Li Y, et al. The ATM Inhibitor KU-55933 Suppresses cell proliferation and induces apoptosis by blocking Akt in cancer cells with overactivated Akt. Mol Cancer Ther. 2010, 9(1): 113-125.
[4] Ivanov VN, et al. Inhibition of ataxia telangiectasia mutated kinase activity enhances TRAIL-mediated apoptosis in human melanoma cells. Cancer Res. 2009, 69(8), 3510-3519.

Please click here to fill online order form, and we will make sure to supply you product with detail information. This process usually takes between 24 to 48 hours, depending on products stock avaliability. All inquires and subsequent projects are handled in the strictest confidence and will be backed by a confidentiality agreement if required.
KareBayTM provides scientists and clinicians with a wide range of biotechnological products and science lab supplies for chemical research and analyzing life processes. KareBay's extensive capabilities include commercializing reagents and kits, manufacturing biotech products and providing contract research services to organizations worldwide. Our many global labs, offices, and business partners enable KareBay to extend its products and services to its customer base around the world.

Our products are used for research, laboratory and further evaluation purposes. They are not for human use.